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Inflammatory myofibroblastic pseudotumour of
the liver in association with gall stones - a rare







Inflammatory myofibroblastic pseudotumours of the liver are rare tumour-like lesions that can mimic malignant
liver neoplasms. The symptoms and radiological findings of this rare tumour can pose diagnostic difficulties. We
describe a 69-year-old gentleman who was admitted to our department with symptoms suggestive of acute chole-
cystitis. Ultrasonography and computed tomography of the liver raised the possibility of metastatic liver disease. A
core biopsy of the liver was performed to confirm the diagnosis of liver metastasis. Unexpectedly it showed no evi-
dence of malignancy but instead revealed an inflammatory myofibroblastic pseudotumour of the liver. This case
report highlights the diagnostic dilemma that arose due to the similarity of appearances between the two patholo-
gical entities on imaging and this stresses the need for accurate histological diagnosis so as to avoid unnecessary
surgical intervention. To the best of our knowledge, only a minority of cases are reported in the literature associat-
ing a hepatic inflammatory myofibroblastic pseudotumour with gall stones.
Background
An inflammatory myofibroblastic pseudotumour (IMFP)
of the liver (also known as a plasma cell granuloma) is a
rare, benign, tumour-like lesion first described in 1953
by Pack and Baker [1]. Histologically, it is characterized
by the presence of proliferating fibrovascular tissue
mixed in with a heterogenous population of acute and
chronic inflammatory cells mainly consisting of plasma
cells, lymphocytes and occasionally histiocytes [2]. The
symptoms and radiological findings of this rare tumour
can mimic malignancy and pose diagnostic difficulties.
IMFPs most often occur in the lung, however have also
been reported in the central nervous system, orbit, and
liver [3]. We describe an unusual case of a 69 year old
man known to suffer with rheumatoid arthritis, who
presented with symptoms of cholecystitis.
Case Presentation
A 69-year-old Caucasian gentleman presented to the
surgical department with right upper quadrant pain,
nausea, vomiting and a recent weight loss. His medical
antecedents included rheumatoid arthritis and bronch-
iectasis. On examination, the patient was found to have
tenderness in the right hypochondrium. An abdominal
ultrasound (US) scan revealed a thick-walled gall blad-
der with multiple calculi and a normal looking liver.
Laboratory investigations showed a decreased haemoglo-
bin concentration (11.6 g/dl), an elevated C-reactive
protein level (137 mg/l) and an increased erythrocyte
sedimentation rate (98 mm/hr). The liver function tests
were deranged with a raised alkaline phosphatase (412
u/l), a raised alanine transaminase (53 u/l) and a normal
serum bilirubin level. An initial diagnosis of cholecystitis
was made and the patient was treated empirically with
antibiotics.
Whilst waiting for a laparoscopic cholecystectomy, the
patient once more presented to the emergency depart-
ment with recurrent episodes of abdominal pain. A
repeat abdominal US scan revealed an ill-defined area in
the right lobe of the liver with altered echogenicity. This
ambiguous region was considered to represent either
metastatic infiltration or an early hepatic abscess. Subse-
quently, computed tomography (CT) revealed multiple
low attenuation lesions in the right lobe of the liver, the
largest measuring 5.5 cms (Fig 1). The lesions demon-
strated patchy central and peripheral enhancement with
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from an unknown primary was made. However, US
guided fine needle aspiration (FNA) of the liver demon-
strated the presence of benign hepatocytes, acellular
debris and a mixture of acute and chronic inflammatory
cells. Surprisingly, no malignant cells were identified. A
core biopsy of the liver revealed predominantly bland
spindle-celled stromal tissue with cellular infiltrate rich
in plasma cells (Fig 2). There was no evidence of malig-
nancy in the tissue examined. A final diagnosis of an
IMFP of the liver was made. During the course of the
investigations the patient had complete symptomatic
relief on oral antibiotics. The patient was followed up
with a repeat CT scan 3 months later which showed a
marked improvement with an almost complete resolu-
tion of the lesions (Fig 3). The patient is asymptomatic
and remains well.
Discussion
An IMFP is a benign, tumour-like mass characterized by
proliferating fibrous tissue infiltrated by inflammatory
cells [2]. This condition is known to occur in several
organs including lymph nodes, spleen, brain, spinal
cord, larynx, thyroid gland, breast, pancreas, gastroin-
testinal (GI) tract and bladder, but most frequently it
occurs in the lungs and liver [3]. Hepatic IMFPs occur
predominantly in the right lobe of the liver although
multicentricity has been described [4] and it has pre-
viously occurred in the gall bladder fossa of the liver [5].
The etiology of IMFPs remains unclear although infec-
tion, radiation and chemotherapy have been suggested as
possible causes [6]. More recently it has been associated
with chronic inflammatory and autoimmune disorders
[3,4], stem cell transplantation[5], Crohn’sd i s e a s e[ 5 ] ,
gastro-intestinal stromal tumours [7], congenital neutro-
penia [8] and pregnancy [9]. This condition can present
as an abdominal mass or with non specific symptoms
such as intermittent fever, abdominal discomfort, weight
loss and malaise. The other presentations include
obstructive jaundice [10], splenomegaly, and portal
hypertension [11]. Laboratory investigations often indi-
cate an ongoing inflammatory process with a leukocytosis
and a raised ESR and CRP, as was evident in our case.
IMFPs most often occur in childhood and early adult-
hood in non-European populations [12]. The male to
female ratio has been previously reported between 1:1
and 3.5:1 [10,12]. Distinctively, our patient was 69-years-
old and of European descent.
Radiological diagnosis of this tumor can be demand-
ing, sonographically the lesion may be hyperechoic,
hypoechoic, or complex in echogenicity. CT imaging
may help alleviate the diagnostic dilemma common to
patients presenting with IMFPs. Enhancement patterns
between hepatocellular carcinoma (HCC) and IMFPs
differ significantly, with HCCs exhibiting hyperdensity
in the arterial phase and hypodensity of the capsule in
the delayed phase. On MRI the lesion demonstrates
increased signal intensity on both T-1 weighted and
Figure 1 CT scan demonstrating several ill-defined low attenuation lesions with some peripheral enhancement.
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[13]. These variable appearances on imaging stress the
need for accurate diagnosis of the tumor by biopsy.
The differential diagnoses on imaging include liver
abscesses, metastasis, peripheral cholangiocarcinoma
and hepatocellular carcinoma. In order to confirm the
diagnosis further, a histological diagnosis of an IMFP
can be made either by FNA or by core biopsy. It is
important to note that despite FNA, IMFPS have been
misdiagnosed as malignant tumours in the past. This is
most likely due to the difficulty in assessing fibrous
lesions with FNA [14].
Figure 2 Medium power histology) showing a bland spindle cell lesion with multiple foci of chronic inflammatory cells
(predominantly mature plasma cells) (X 20, Magnification, H&E stain).
Figure 3 CT scan showing a marked reduction in size of the hepatic lesions. A small organised subcapsular haematoma is noted as result
of previous biopsy.
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nized structures with whorl-like patterns of dense col-
lagen bundles infiltrated by multiple inflammatory cells.
No features of malignancy are present. There is great
histological variation and the features of IMFPs tend to
be non-specific. This has led to IMFPs becoming a diag-
nosis of exclusion in adults [14].
To the best of our knowledge, only a minority of cases
associating hepatic IMFP with gall stones are reported
in the literature [12]. The exact etiological link between
the two is uncertain. However, the presence of gall
stones could potentially enhance entry of enteric bac-
teria into the portal circulation, which might then result
in an inflammatory response and possibly an IMFP.
The management of an IMFP of the liver has tradi-
tionally been surgical but more recently spontaneous
regression of the tumour has been reported with the use
of antibiotics or non-steroidal anti-inflammatories as
was evident in our patient [11,12,15]. Surgery is recom-
mended to relieve obstructive jaundice due to IMFPs.
Currently, there are no clinical studies comparing the
outcomes of patients treated conservatively and those
treated with surgery. Also, there is no data regarding the
duration of follow up in patients managed conservatively
[16]. More recently local recurrence and distant metas-
t a s e sh a v eb e e na t t r i b u t e dt ot h ep l o i d yo ft h el e s i o n
with aneuploid lesions more likely to recur and metasta-
size than diploid lesions [17]. Therefore flow cytometric
DNA analysis of these tumours has been suggested to
provide the clinician with both diagnostic and prognos-
tic information and to individualize the most feasible
therapeutic approach [18].
In conclusion this case report emphasizes the impor-
tance of considering an IMFP as part of the differential
diagnosis and highlights that a conservative approach to
a patient with an IMFP is an effective treatment option.
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